An interventional study of Buteyko Breathing Technique in Childhood Asthma, sponsored by Mansoura University. Completed at 1 site in Egypt. Open to participants aged 6 Years to 12 Years. Per ClinicalTrials.gov, last updated 2022-05-25.
Sponsored by Mansoura University · Not applicable, Interventional, and Supportive care
Asthma is a complex condition that can impair not only the child's physical growth but also his optimal functional capacity and performance. Buteyko Breathing Technique (BBT) is an exercise designed to regulate the breathing process. The Buteyko technique also proposes lifestyle changes beyond breathing, including diet, allergy avoidance, and stress control. This study aims to evaluate the effect of the Buteyko breathing technique on asthma severity control among school-age children. In Egypt, this technique was applied through five studies, four among adult patients and only one among children. At Mansoura University, only one study was conducted among adult patients, and no studies were conducted among children. To fulfill this knowledge gap, it is necessary to study the effect of this technique on asthma severity control among school-age children. This study will use the Childhood Asthma Control, Peak Expiratory Flow Rate, and Control Pause tests to evaluate the children's asthma severity control.
Methods
Research design:
A quasi-experimental design, one group pre and post-test will be used to conduct this study.
Study setting:
The study will be conducted at the out-patient clinics of Mansoura University Children Hospital (MUCH), which provides health services to children cases from the Dakhlia governorate and Delta region as asthmatic children routinely come to follow up on their condition with their parents.
Subjects:
The sample size cannot be calculated as there is no specific annual statistical report about the admitted asthma condition to the sensitivity clinic, so a convenient sample of asthmatic school-age children who fulfills the following criteria through the data collection period (3 month) will be recruited.
Ethical considerations:
Data collection tools: Data will be collected using the following three tools.
I. Tool one; Structured interview sheet for children and their mothers.
It consisted of two parts as follow:
II. Tool two; Peak Expiratory Flow Rate (PEFR) test
Steps of PEFR assessment:
- Determining the percentage of PEFR, which equals: [PEFR% = (measured PEFR \ Predicted PEFR) ×100].
- The predicted PEFR will be calculated using the child's height by the following formula: [Predicted average PEF [L/min] = (Body height [cm] x 5.3) - 433] (Kopač, 2017).
The actual PEFR will be estimated by:
This will be replicated three times by each child, and the highest reading will be recorded. ( American Lung Association 2019).
III. Tool three; Control Pause Test (CP) adopted from Buteyko Clinic International (2014).
Evaluating the Control Pause Breathing test using the following steps:
Study intervention:
A. The preparatory phase:
B. Exploratory phase:
Fieldwork
Before the intervention: at the first-week session (1-W):
1- An individualized interview with the children and the caregiver will be conducted at the beginning of the first-week session, where the parent will sign the informed consent. Then All the study tools (C-ACT, PEFR, and CPT) will be assessed before the intervention to determine the baseline data.
During the intervention: at first, second, third, and fourth-week sessions (1-W, 2-W, 3-W, 4-W):
Demonstrating Buteyko Breathing Technique (BBT) until the child adequately understands its steps. Starting with the steps of the first-week session then, adding the newly learned steps of each following week accordingly (1-W, 1+2-W, 1+2+3-W, 1+2+3+4-W) as follows:
Week one exercise:
Week two exercise
Week three and four
After the intervention: at the fourth-week session (4-W):
Mansoura University is the lead sponsor of 1,115 studies on the registry; 184 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
single group pre-post test
Behavioral: Buteyko Breathing Technique
* The child was instructed to sit and take a relaxed posture in a vertical chair, relax his shoulders and lean his lower back against the back of the chair. * Until conducting CP, the child was told to avoid alternate breathing, the child was asked to take a small breath in (two seconds), a small breath out (three seconds) and clutch the nose with empty lungs but not too clear on the 'out-breath. To prevent air from escaping through the airways, clutching the nose is necessary. * The researcher estimates how many seconds the child can continue safely before the need to breathe in again, * The child was told to hold their breath until the first need to breathe in was felt. Release the nose then and naturally breathe through it smoothly. * The first intake of breath after the CP should be no higher than the breath before taking the measurement; the child should not hold the breath for too long as this could lead the child to take a major breath after measuring the CP.
Also known as: Breathing Exercises
Childhood Asthma Control Test(C-ACT)
The tool is a valid test established by GlaxoSmithKline that involves seven questions to evaluate asthma control and the effects of asthma on diurnal activities among school age children. It has seven questions; the first four are answered by the children and the last three by their parents. Each question had four answer options for children, and six answer options for parents. This part completed at the first and final sessions as a pre and posttest. Its scores were categorized as the following: * 20:27 good asthma control * 10:19 moderate asthma control * Less than 10 poorly asthma control
Time frame: 4 weeks
Peak Expiratory Flow Rate (PEFR)
The Peak Expiratory Flow Rate (PEFR) is person's maximum speed of expiration. It is measured with a mini wright peak flow meter device to display person's capability to expire out air through the bronchi. Therefore, it gives an understanding of the extent of obstruction in the airway. The predicted PEFR was calculated and compared with the actual value to determine the level of airway obstruction. Its interpretations are often categorized into three zones of depth; green, yellow, and red * Green zone: The peak flow result is between 80-100% of the child's predicted value. This is the clear zone. * Yellow zone: Peak flow result is between 50-79% of the child's predicted value. This is the caution zone. * Red zone: Peak flow result is less than 50% of the child's predicted value. This is an asthma crisis.
Time frame: 4 weeks
Control Pause Test (CP)
It was established by Dr. Buteyko to assess the depth of breathing and consequent retention of carbon dioxide, resultant oxygenation and health by using special breathing holding manner. This acts as a natural peak flow meter and it was used as diagnostic and therapeutic technique as it one of the major techniques of BBT. The scoring was categorized as follow: * Less than 10: health is severely affected. * 10 to less than 20: patient probably suffering from a chronic illness, along with symptoms, such as blocked nose, snoring, insomnia, coughing, short breath, asthma. * 20 to less than 40: most symptoms are not there, but may occur following a triggering event. * 40 and more: good health.
Time frame: 4 weeks
This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.